COX-2 (cyclooxygenase-2)/PGE2 (prostaglandin E2) pathway can support IDO1 constitutive expression in NSCLC; downstream β-catenin and ETV4 can bind to IDO1 promoter and promote IDO1 transcription (167). Here, IDO1 is linked to non-small cell lung carcinoma.